Advertisement Adaltis names new COO for China - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Adaltis names new COO for China

Adaltis, an international in vitro diagnostic company, has appointed Mr Frederick Leung to the newly created position of COO - China, reporting to Raymond Tong, COO of the company.

Prior to joining Adaltis, Mr Leung worked for Siemens Healthcare Diagnostics’s Asia-Pacific operation, in a strategic development role.

Raymond Tong, COO of Adaltis, said: “The company’s plan is to continuously leverage the investments in our China-based operations, particularly our Shanghai manufacturing facility. Mr Leung’s addition to our China team is an important step towards this direction. One of his main focuses will be on pushing the sales of our infectious disease products in China and Asia, as well as the penetration of Eclectica, our system targeting small and medium size laboratories.”